{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:45:35Z","timestamp":1778589935577,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.neuint.2010.02.015","type":"journal-article","created":{"date-parts":[[2010,3,8]],"date-time":"2010-03-08T07:47:58Z","timestamp":1268034478000},"page":"774-779","source":"Crossref","is-referenced-by-count":19,"title":["Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients"],"prefix":"10.1016","volume":"56","author":[{"given":"Mercedes","family":"Zum\u00e1rraga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nieves","family":"Basterreche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Arrue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biotza","family":"Goienetxea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda I.","family":"Zamalloa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leire","family":"Erkoreka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Inchausti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Gonz\u00e1lez-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Guim\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2010.02.015_bib1","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1523\/JNEUROSCI.23-06-02008.2003","article-title":"Catechol-O-methyltransferase genotype and dopamine regulation in the human brain","volume":"23","author":"Akil","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2010.02.015_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00439-001-0652-8","article-title":"Investigation of the functional effect of monoamine oxidase polymorphisms in human brain","volume":"110","author":"Balciuniene","year":"2002","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neuint.2010.02.015_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000170391","article-title":"Biological correlates of the congruence and incongruence of psychotic symptoms in patients with type 1 bipolar disorder","volume":"58","author":"Basterreche","year":"2008","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuint.2010.02.015_bib4","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1176\/appi.ajp.2007.07010217","article-title":"Elevated plasma dopamine metabolites in cannabis psychosis","volume":"164","author":"Bowers","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuint.2010.02.015_bib5","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.7792602","article-title":"Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA","volume":"268","author":"Cases","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neuint.2010.02.015_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1126\/science.1072290","article-title":"Role of genotype in the cycle of violence in maltreated children","volume":"297","author":"Caspi","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuint.2010.02.015_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jpsychires.2006.10.009","article-title":"Psychopathological and nutritional correlates of plasma homovanillic acid in adolescents with anorexia nervosa","volume":"42","author":"Castro-Fornieles","year":"2008","journal-title":"J. Psychiatry Res."},{"key":"10.1016\/j.neuint.2010.02.015_bib8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/425589","article-title":"Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain","volume":"75","author":"Chen","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuint.2010.02.015_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/archpsyc.1991.01810250075011","article-title":"Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation","volume":"48","author":"Davidson","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuint.2010.02.015_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.psychres.2005.07.039","article-title":"Plasma Homovanillic acid levels in schizophrenic patients: correlation with negative symptoms","volume":"151","author":"D\u00e1vila","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuint.2010.02.015_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0278-5846(91)90025-V","article-title":"The effect of age, sex, weight and height on the plasma concentrations in healthy subjects of the acidic metabolites of some biogenic monoamines involved in psychiatric and neurological disorders","volume":"15","author":"Davis","year":"1991","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2010.02.015_bib12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/hmg\/8.4.621","article-title":"Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder","volume":"8","author":"Deckert","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2010.02.015_bib13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00439-002-0809-0","article-title":"Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation","volume":"111","author":"DeMille","year":"2002","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neuint.2010.02.015_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biopsych.2007.03.031","article-title":"Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls","volume":"63","author":"Diaz-Asper","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2010.02.015_bib15","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1073\/pnas.111134598","article-title":"Effect of COMT Val108\/158 Met genotype on frontal lobe function and risk for schizophrenia","volume":"98","author":"Egan","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuint.2010.02.015_bib16","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00702-007-0793-6","article-title":"Homovanillic acid (HVA) plasma levels inversely correlate with attention deficit-hyperactivity and childhood neglect measures in addicted patients","volume":"114","author":"Gerra","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuint.2010.02.015_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1677\/joe.1.06307","article-title":"The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects","volume":"187","author":"Giltay","year":"2005","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.neuint.2010.02.015_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0006-3223(89)90034-6","article-title":"The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia","volume":"26","author":"Glazer","year":"1989","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2010.02.015_bib19","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.95.17.9991","article-title":"Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior","volume":"95","author":"Gogos","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuint.2010.02.015_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1176\/ajp.154.1.113","article-title":"Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder","volume":"154","author":"Guti\u00e9rrez","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuint.2010.02.015_bib21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.eurpsy.2007.02.002","article-title":"Role of the COMT gene Val158Met polymorphism in mental disorders: a review","volume":"22","author":"Hos\u00e1k","year":"2007","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.neuint.2010.02.015_bib22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF02429064","article-title":"Effect of age on homovanillic and 4-hydroxy-3-methoxymandelic acid levels in plasma","volume":"145","author":"Hunneman","year":"1986","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.neuint.2010.02.015_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0920-9964(02)00224-4","article-title":"Association between a promoter variant in the monoamine oxidase A gene and schizophrenia","volume":"61","author":"Jonsson","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuint.2010.02.015_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0920-9964(99)00171-1","article-title":"Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics","volume":"44","author":"Kim","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuint.2010.02.015_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00008571-199606000-00007","article-title":"Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders","volume":"6","author":"Lachman","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.neuint.2010.02.015_bib26","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s11064-008-9851-1","article-title":"Plasma homovanillic acid and prolactin in Huntington's disease","volume":"34","author":"Markianos","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2010.02.015_bib27","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1073\/pnas.0931309100","article-title":"Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine","volume":"100","author":"Mattay","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuint.2010.02.015_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autneu.2004.08.013","article-title":"Assessment of O-methylated catecholamines levels in plasma and urine for diagnosis of autonomic disorders","volume":"116","author":"Oeltmann","year":"2004","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.neuint.2010.02.015_bib29","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.pnpbp.2008.02.009","article-title":"Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study","volume":"32","author":"Okamoto","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2010.02.015_bib30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archpsyc.1986.01800070059008","article-title":"Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment","volume":"43","author":"Pickar","year":"1986","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuint.2010.02.015_bib31","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/clinchem\/33.6.844","article-title":"Determination of free 3-methoxy-4-hydroxyphenylethyleneglycol in plasma and in cerebrospinal fluid by liquid chromatography with coulometric detection","volume":"33","author":"Rizzo","year":"1987","journal-title":"Clin. Chem."},{"key":"10.1016\/j.neuint.2010.02.015_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1176\/appi.ajp.159.1.23","article-title":"Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder","volume":"159","author":"Rotondo","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuint.2010.02.015_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-1781(02)00245-7","article-title":"Eye movement disturbances in schizophrenia and a polymorphism of catechol-O-methyltransferase gene","volume":"113","author":"Rybakowski","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuint.2010.02.015_bib34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s004390050816","article-title":"A functional polymorphism in the monoamine oxidase A gene promoter","volume":"103","author":"Sabol","year":"1998","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neuint.2010.02.015_bib35","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/1096-8628(20001204)96:6<801::AID-AJMG21>3.0.CO;2-4","article-title":"Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder","volume":"96","author":"Schulze","year":"2000","journal-title":"Am. J. Med. Genet., Part B, Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuint.2010.02.015_bib36","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1086\/344514","article-title":"A highly significant association between a COMT haplotype and schizophrenia","volume":"71","author":"Shifman","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuint.2010.02.015_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0165-1781(93)90034-E","article-title":"Serum homovanillic acid levels in schizophrenic patients and normal control subjects","volume":"48","author":"Steinberg","year":"1993","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuint.2010.02.015_bib38","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0006-3223(96)00099-6","article-title":"Sex differences in plasma homovanillic acid levels in schizophrenia and normal controls: relation to neuroleptic resistance","volume":"41","author":"Sumiyoshi","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2010.02.015_bib39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ajmg.1193","article-title":"Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders","volume":"105","author":"Syagailo","year":"2001","journal-title":"Am. J. Med. Genet., Part B, Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuint.2010.02.015_bib40","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/cercor\/bhl032","article-title":"Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan","volume":"17","author":"Tunbridge","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuint.2010.02.015_bib41","first-page":"10","article-title":"Plasma hormones and catecholamine metabolites in monozygotic twins discordant for psychosis","volume":"15","author":"Walker","year":"2002","journal-title":"Neuropsychiatry Neuropsychol. Behav. Neurol."},{"key":"10.1016\/j.neuint.2010.02.015_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.pharmtox.39.1.19","article-title":"Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase","volume":"39","author":"Weinshilboum","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuint.2010.02.015_bib43","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1210\/jc.77.3.794","article-title":"Genetic influences on plasma catecholamines in human twins","volume":"77","author":"Williams","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuint.2010.02.015_bib44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/hup.804","article-title":"Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders","volume":"21","author":"Yoshimura","year":"2006","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuint.2010.02.015_bib45","first-page":"109","article-title":"Determinaci\u00f3n simult\u00e1nea de dopamina y \u00e1cido 3,4 dihidroxifenilac\u00e9tico en orina por HPLC y detecci\u00f3n amperom\u00e9trica","volume":"3","author":"Zum\u00e1rraga","year":"1984","journal-title":"Biom\u00e9trica"},{"key":"10.1016\/j.neuint.2010.02.015_bib46","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/clinchem\/40.11.2119","article-title":"Homovanillic acid in plasma determined by HPLC with direct injection of plasma filtrates","volume":"40","author":"Zum\u00e1rraga","year":"1994","journal-title":"Clin. Chem."},{"key":"10.1016\/j.neuint.2010.02.015_bib47","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.pnpbp.2007.01.005","article-title":"Inter- and intra-individual variability in the levels of plasma homovanillic acid in schizophrenic patients","volume":"31","author":"Zum\u00e1rraga","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018610000847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018610000847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T23:50:34Z","timestamp":1590709834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018610000847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":47,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0197018610000847"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2010.02.015","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}